Rebecca Li1,2, Megan von Isenburg3, Marcia Levenstein4, Stan Neumann4, Julie Wood4, Ida Sim4,5. 1. Vivli, Cambridge, USA. rli@vivli.org. 2. Harvard, Center for Bioethics, Boston, MA, USA. rli@vivli.org. 3. Duke University, Durham, NC, USA. 4. Vivli, Cambridge, USA. 5. University of California, San Francisco, CA, USA.
Abstract
BACKGROUND: The sharing of individual participant-level data from COVID-19 trials would allow re-use and secondary analysis that can help accelerate the identification of effective treatments. The sharing of trial data is not the norm, but the unprecedented pandemic caused by SARS-CoV-2 may serve as an impetus for greater data sharing. We sought to assess the data sharing intentions of interventional COVID-19 trials as declared in trial registrations and publications. METHODS: We searched ClinicalTrials.gov and PubMed for COVID-19 interventional trials. We analyzed responses to ClinicalTrials.gov fields regarding intent to share individual participant level data and analyzed the data sharing statements in eligible publications. RESULTS: Nine hundred twenty-four trial registrations were analyzed. 15.7% were willing to share, of which 38.6% were willing to share immediately upon publication of results. 47.6% declared they were not willing to share. Twenty-eight publications were analyzed representing 26 unique COVID-19 trials. Only seven publications contained data sharing statements; six indicated a willingness to share data whereas one indicated that data was not available for sharing. CONCLUSIONS: At a time of pressing need for researchers to work together to combat a global pandemic, intent to share individual participant-level data from COVID-19 interventional trials is limited.
BACKGROUND: The sharing of individual participant-level data from COVID-19 trials would allow re-use and secondary analysis that can help accelerate the identification of effective treatments. The sharing of trial data is not the norm, but the unprecedented pandemic caused by SARS-CoV-2 may serve as an impetus for greater data sharing. We sought to assess the data sharing intentions of interventional COVID-19 trials as declared in trial registrations and publications. METHODS: We searched ClinicalTrials.gov and PubMed for COVID-19 interventional trials. We analyzed responses to ClinicalTrials.gov fields regarding intent to share individual participant level data and analyzed the data sharing statements in eligible publications. RESULTS: Nine hundred twenty-four trial registrations were analyzed. 15.7% were willing to share, of which 38.6% were willing to share immediately upon publication of results. 47.6% declared they were not willing to share. Twenty-eight publications were analyzed representing 26 unique COVID-19 trials. Only seven publications contained data sharing statements; six indicated a willingness to share data whereas one indicated that data was not available for sharing. CONCLUSIONS: At a time of pressing need for researchers to work together to combat a global pandemic, intent to share individual participant-level data from COVID-19 interventional trials is limited.
Authors: Darren B Taichman; Peush Sahni; Anja Pinborg; Larry Peiperl; Christine Laine; Astrid James; Sung-Tae Hong; Abraham Haileamlak; Laragh Gollogly; Fiona Godlee; Frank A Frizelle; Fernando Florenzano; Jeffrey M Drazen; Howard Bauchner; Christopher Baethge; Joyce Backus Journal: Ann Intern Med Date: 2017-06-06 Impact factor: 25.391
Authors: Kristina Larson; Ida Sim; Megan von Isenburg; Marcia Levenstein; Frank Rockhold; Stan Neumann; Catherine D'Arcy; Elizabeth Graham; David Zuckerman; Rebecca Li Journal: Contemp Clin Trials Date: 2022-02-16 Impact factor: 2.261
Authors: Laura Merson; Duduzile Ndwandwe; Thobile Malinga; Giuseppe Paparella; Kwame Oneil; Ghassan Karam; Robert F Terry Journal: Wellcome Open Res Date: 2022-03-21
Authors: Nachiket Gudi; Prashanthi Kamath; Trishnika Chakraborty; Anil G Jacob; Shradha S Parsekar; Suptendra Nath Sarbadhikari; Oommen John Journal: J Med Internet Res Date: 2022-05-04 Impact factor: 7.076